Annelies Wilder-Smith Selected Research

Dengue (Dengue Fever)

1/2021	Novel vaccine safety issues and areas that would benefit from further research.
1/2020	Modelling the effect of a dengue vaccine on reducing the evolution of resistance against antibiotic due to misuse in dengue cases.
1/2020	Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients.
1/2020	Dengue vaccine development by the year 2020: challenges and prospects.
1/2020	Dengue vaccine development: status and future.
10/2019	Severe dengue in travellers: pathogenesis, risk and clinical management.
1/2019	Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines.
1/2019	Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.
1/2019	Dengue virus-elicited tryptase induces endothelial permeability and shock.
1/2019	Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annelies Wilder-Smith Research Topics

Disease

41	Dengue (Dengue Fever) 01/2021 - 02/2004
18	Infections 01/2022 - 01/2009
11	Severe Dengue 01/2020 - 05/2010
9	COVID-19 01/2022 - 10/2020
8	Human Influenza (Influenza) 01/2019 - 12/2009
7	Meningococcal Infections 10/2012 - 02/2003
6	Malaria 01/2021 - 01/2004
5	Zika Virus Infection 12/2020 - 01/2017
5	Yellow Fever 10/2019 - 07/2008
4	Meningitis 01/2021 - 10/2007
4	Fever (Fevers) 01/2020 - 06/2014
3	Hepatitis A (Hepatitis, Infectious) 10/2019 - 09/2011
3	Vaccine-Preventable Diseases 10/2019 - 01/2012
3	Tetanus 10/2017 - 05/2007
3	Diphtheria 10/2017 - 05/2007
3	Whooping Cough (Pertussis) 05/2010 - 11/2003
2	Japanese Encephalitis 10/2019 - 08/2009
2	Rabies (Hydrophobia) 10/2019 - 11/2011
2	Viremia 01/2016 - 01/2009
2	Communicable Diseases (Infectious Diseases) 01/2012 - 01/2004
2	Cough 05/2007 - 11/2003
1	Breakthrough Infections 01/2022
1	Narcolepsy 01/2021
1	Intussusception 01/2021
1	Postural Orthostatic Tachycardia Syndrome 01/2021
1	Complex Regional Pain Syndromes 01/2021
1	Cerebral Malaria 01/2021
1	Hypovolemia 01/2020
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Hepatitis B 10/2019
1	Shock 01/2019
1	Obesity 11/2017
1	Pneumonia (Pneumonitis) 04/2016
1	Gastroenteritis 04/2016
1	Necrotizing Pneumonia 07/2014
1	Soft Tissue Infections 07/2014
1	Neutropenia 06/2014
1	Bacterial Infections (Bacterial Infection) 06/2014
1	Bites and Stings (Sting) 03/2013
1	Parasitic Diseases (Parasitic Disease) 12/2012
1	Hemolysis 01/2012
1	Leprosy (Hansen's Disease) 01/2012
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 11/2011
1	Hepatitis 09/2011
1	Mucocutaneous Leishmaniasis 09/2011
1	Leptospirosis 09/2011
1	Nausea 09/2011
1	Onchocerciasis 09/2011
1	Headache (Headaches) 09/2011
1	Chagas Disease (American Trypanosomiasis) 09/2011

Drug/Important Bio-Agent (IBA)

45	VaccinesIBA 01/2022 - 01/2002
17	Dengue VaccinesIBA 01/2021 - 07/2008
6	InsecticidesIBA 01/2017 - 07/2011
5	Antiviral Agents (Antivirals)IBA 08/2016 - 12/2009
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 11/2011
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 11/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2003
4	Permethrin (Ambush)FDA LinkGeneric 01/2017 - 01/2014
4	Meningococcal Vaccines (Meningococcal Vaccine)IBA 10/2012 - 02/2003
3	AntibodiesIBA 01/2016 - 02/2004
3	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 11/2011 - 05/2010
2	Rotavirus VaccinesIBA 01/2021 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2016
2	Chymases (Chymase)IBA 01/2020 - 11/2017
2	Attenuated VaccinesIBA 01/2020 - 01/2020
2	Combined VaccinesIBA 01/2018 - 02/2003
2	Pertussis VaccineIBA 10/2017 - 05/2007
2	AntigensIBA 03/2015 - 11/2003
2	RNA (Ribonucleic Acid)IBA 03/2015 - 09/2011
2	Chloroquine (Aralen)FDA LinkGeneric 01/2015 - 09/2011
1	COVID-19 VaccinesIBA 01/2022
1	Malaria VaccinesIBA 01/2021
1	adjuvant system 01IBA 01/2021
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021
1	Nucleic AcidsIBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Tryptases (Tryptase)IBA 01/2019
1	Guanosine Diphosphate (GDP)IBA 01/2019
1	Biological ProductsIBA 01/2018
1	CytokinesIBA 12/2016
1	ChemokinesIBA 12/2016
1	Interleukin-10 (Interleukin 10)IBA 12/2016
1	Dihydrotachysterol (AT 10)IBA 11/2016
1	Greenhouse GasesIBA 05/2016
1	Immunoglobulin M (IgM)IBA 02/2016
1	6-sulfo sialyl Lewis XIBA 03/2015
1	Complement System Proteins (Complement)IBA 03/2015
1	Leukocidins (Leukocidin)IBA 07/2014
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2014
1	Moclobemide (Arima)IBA 01/2012
1	1-dodecylpyridoxal (PLD)IBA 01/2012
1	Cholera Vaccines FDA Link 11/2011

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2013
1	Patient Isolation 11/2020
1	Critical Care (Surgical Intensive Care) 10/2020
1	Fluid Therapy (Oral Rehydration Therapy) 10/2019
1	Length of Stay 06/2014